Boston Scientific, Edwards and Dexcom usher in second week of earnings

The second wave of the medtech industry’s latest earnings season arrives this week, with Boston Scientific, Edwards Lifesciences and Dexcom all set to report their financial results.

Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. J&J relied on acquisition-driven growth in cardiovascular sales to offset weakness elsewhere. However, CFO Joe Wolk conceded that adjusted operating medtech sales would likely grow closer to 5% than the previously forecast 6%.